Triple-negative breast cancer (TNBC) is characterized by the lack of ESR (estrogen receptor) and PGR (progesterone receptor) expression and the absence of ERBB2/HER2 (erb-b2 receptor tyrosine kinase 2) overexpression or gene amplification [2]. This evidence concerns the gene PGR and triple-negative breast carcinoma.